首页> 外文期刊>Applied Microbiology >Coupling the CRISPR/Cas9 System with Lambda Red Recombineering Enables Simplified Chromosomal Gene Replacement in Escherichia coli
【24h】

Coupling the CRISPR/Cas9 System with Lambda Red Recombineering Enables Simplified Chromosomal Gene Replacement in Escherichia coli

机译:将CRISPR / Cas9系统与Lambda Red重组结合在一起,可简化大肠杆菌中的染色体基因置换

获取原文
       

摘要

To date, most genetic engineering approaches coupling the type II Streptococcus pyogenes clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 system to lambda Red recombineering have involved minor single nucleotide mutations. Here we show that procedures for carrying out more complex chromosomal gene replacements in Escherichia coli can be substantially enhanced through implementation of CRISPR/Cas9 genome editing. We developed a three-plasmid approach that allows not only highly efficient recombination of short single-stranded oligonucleotides but also replacement of multigene chromosomal stretches of DNA with large PCR products. By systematically challenging the proposed system with respect to the magnitude of chromosomal deletion and size of DNA insertion, we demonstrated DNA deletions of up to 19.4 kb, encompassing 19 nonessential chromosomal genes, and insertion of up to 3 kb of heterologous DNA with recombination efficiencies permitting mutant detection by colony PCR screening. Since CRISPR/Cas9-coupled recombineering does not rely on the use of chromosome-encoded antibiotic resistance, or flippase recombination for antibiotic marker recycling, our approach is simpler, less labor-intensive, and allows efficient production of gene replacement mutants that are both markerless and “scar”-less.
机译:迄今为止,大多数遗传工程方法将化脓性链球菌II型链球菌以规则间隔的短回文重复序列(CRISPR)/ Cas9系统与lambda Red重组结合,涉及较小的单核苷酸突变。在这里,我们显示通过进行CRISPR / Cas9基因组编辑,可大大增强在大肠杆菌中进行更复杂的染色体基因置换的程序。我们开发了一种三质粒方法,该方法不仅允许短单链寡核苷酸的高效重组,而且可以用大型PCR产物代替DNA的多基因染色体片段。通过就染色体缺失的大小和DNA插入的大小系统地挑战拟议的系统,我们证明了高达19.4 kb的DNA缺失,包括19个非必需的染色体基因,以及高达3 kb的异源DNA的插入,并具有重组效率通过菌落PCR筛选进行突变检测。由于CRISPR / Cas9偶联重组不依赖于使用染色体编码的抗生素抗性或翻转酶重组来进行抗生素标记物的回收,因此我们的方法更简单,劳动强度更低,并且可以高效生产无标记的基因替代突变体和“少疤痕”。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号